To explore whether targeting the GFPT2- O-GlcNAcylation signal axis has potential clinical significance, we used KPC cells to construct the subcutaneous implant tumor model in C57BL/6 mice, and OSIM-1 was injected intraperitoneally every other day (Fig. 8H). Here, GFPT2 is linked to neoplasm.